Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Cash from Operations: 2018-2024

Historic Cash from Operations for Eton Pharmaceuticals (ETON) over the last 7 years, with Dec 2024 value amounting to $969,000.

  • Eton Pharmaceuticals' Cash from Operations rose 307.38% to $12.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $21.3 million, marking a year-over-year increase of 904.71%. This contributed to the annual value of $969,000 for FY2024, which is 85.78% down from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Cash from Operations of $969,000 as of FY2024, which was down 85.78% from $6.8 million recorded in FY2023.
  • Eton Pharmaceuticals' 5-year Cash from Operations high stood at $6.8 million for FY2023, and its period low was -$22.3 million during FY2020.
  • In the last 3 years, Eton Pharmaceuticals' Cash from Operations had a median value of $4.8 million in 2022 and averaged $4.2 million.
  • As far as peak fluctuations go, Eton Pharmaceuticals' Cash from Operations skyrocketed by 202.12% in 2022, and later crashed by 85.78% in 2024.
  • Yearly analysis of 5 years shows Eton Pharmaceuticals' Cash from Operations stood at -$22.3 million in 2020, then surged by 78.87% to -$4.7 million in 2021, then surged by 202.12% to $4.8 million in 2022, then skyrocketed by 41.36% to $6.8 million in 2023, then slumped by 85.78% to $969,000 in 2024.